TickerFactsScreenerDevelopers

Galmed Pharmaceuticals Ltd. (GLMD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$8.47M2016: -$12.13M2017: -$12.07M2018: -$9.02M2019: -$14.94M2020: -$26.29M2021: -$32.89M2022: -$18.50M2023: -$6.14M2024: -$5.88M2025: -$6.32M-$6.32M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.32M-7.4%
2024-$5.88M+4.2%
2023-$6.14M+66.8%
2022-$18.50M+43.8%
2021-$32.89M-25.1%
2020-$26.29M-76.0%
2019-$14.94M-65.5%
2018-$9.02M+25.2%
2017-$12.07M+0.5%
2016-$12.13M-43.1%
2015-$8.47M—